ClinicalTrials.gov
ClinicalTrials.gov Menu

Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00519948
Recruitment Status : Completed
First Posted : August 23, 2007
Last Update Posted : June 19, 2008
Sponsor:
Information provided by:
Innovative Medical

Brief Summary:
To compare patient comfort and overall lens cleanliness with consecutive use of two multipurpose lens solutions.

Condition or disease Intervention/treatment Phase
Patient Comfort Lens Cleanliness Drug: new MPS, opti-free express no rub MPS Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Actual Primary Completion Date : June 2008
Actual Study Completion Date : June 2008




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  1. Patients 18 yrs or older
  2. Males or females
  3. Any race or ethnic background
  4. CL patients using Opti-Free Express no-rub MPS currently
  5. Patients using Focus night and day Lenses

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Corneal ectasia.
  3. Current use of Restasis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00519948


Locations
United States, Texas
Eyeworks Group
Fort Worth, Texas, United States, 76132
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Robert Chu, OD Eyeworks Group

Responsible Party: Dr. Chu, Eyeworks Group
ClinicalTrials.gov Identifier: NCT00519948     History of Changes
Other Study ID Numbers: 5320
First Posted: August 23, 2007    Key Record Dates
Last Update Posted: June 19, 2008
Last Verified: June 2008